FrancophonIA/ELRC3.0 huggingface dataset:
English: Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine.
Slovenian: Bolniki z redko dedno intoleranco za fruktozo, malabsorpcijo glukoze/galaktoze ali pomanjkanjem saharaze-izomaltaze ne smejo jemati tega zdravila
English: The dose may be adjusted up to 120 mg a day based on your response to Cymbalta.
Slovenian: Odmerek bo morda prilagojen do 120 mg na dan, glede na vaš odziv na zdravilo Cymbalta.
English: You should use Cymbalta only after discussing the potential benefits and any potential risks to your unborn child with your doctor.
Slovenian: Zdravilo Cymbalta lahko uporabljate le po tem, ko ste se o možnih koristih in morebitnih možnih tveganjih za vašega nerojenega otroka pogovorili s svojim zdravnikom.
English: Cymbalta should be used in pregnancy only if the potential benefit justifies the potential risk to the foetus.
Slovenian: Zdravilo Cymbalta naj se v nosečnosti uporablja le, če možna korist upravičuje možno tveganje za plod.
English: The primary outcome measure was the weekly mean of 24-hour average pain, which was collected in a daily diary by patients on an 11-point Likert scale.
Slovenian: Primarna mera izida je bilo tedensko povprečje 24-urne povprečne bolečine, kar smo zbrali iz dnevnih dnevnikov bolnikov na podlagi 11-točkovne
English: Cymbalta may be associated with sedation and dizziness.
Slovenian: Cymbalta je lahko povezana s sedacijo in omotico.
English: − are taking other medicines containing duloxetine (see ‘Other medicines and Cymbalta')
Slovenian: - jemljete druga zdravila, ki vsebujejo duloksetin (glejte »Druga zdravila in zdravilo Cymbalta«)
English: Despite this, your doctor may prescribe Cymbalta for patients under 18 because he/she decides that this is in their best interests.
Slovenian: Temu navkljub lahko vaš zdravnik predpiše zdravilo Cymbalta tudi bolnikom, mlajšim od 18 let, če se odloči, da je to v njihovo najboljšo korist.
English: Cymbalta starts to work in most people with depression or anxiety within two weeks of starting treatment, but it may take 2-4 weeks before you feel better.
Slovenian: Pri večini bolnikov z depresijo ali anksioznostjo začne zdravilo Cymbalta delovati v dveh tednih po začetku zdravljenja, lahko pa traja 2 do 4 tedne, preden se boste počutili boljše.
English: The following are reasons why Cymbalta may not be suitable for you.
Slovenian: Spodaj so našteti razlogi, zaradi katerih morda zdravilo Cymbalta za vas ni ustrezna.
English: If your doctor thinks that you no longer need Cymbalta he or she will ask you to reduce your dose over at least 2 weeks before stopping treatment altogether.
Slovenian: Če bo vaš zdravnik menil, da zdravila Cymbalta ne potrebujete več, vam bo naročil-a, da pred prenehanjem zdravljenja 2 tedna postopoma znižujte svoj odmerek.
English: Cymbalta is available in 2 strengths: 30 mg and 60 mg.
Slovenian: Cymbalta je na voljo v dveh jakostih: 30 mg in 60 mg.
English: However, as with any medicine, caution should be exercised when treating the elderly, especially with Cymbalta 120 mg per day for major depressive disorder or generalised anxiety disorder, for which data are limited (see sections 4.4 and 5.2).
Slovenian: Vendar pa je, kot pri vseh zdravilih, pri zdravljenju starejših potrebna previdnost, posebno z zdravilom Cymbalta 120 mg na dan za zdravljenje velike depresivne motnje ali generalizirane anksiozne motnje, za kar je na voljo malo podatkov (glejte poglavji 4.4 in 5.2).
English: What Cymbalta is and what it is used for
Slovenian: Kaj je zdravilo Cymbalta in za kaj ga uporabljamo
English: If your doctor has prescribed Cymbalta for a patient under 18 and you want to discuss this, please go back to your doctor.
Slovenian: Če je vaš zdravnik predpisal zdravilo Cymbalta bolniku, mlajšemu od 18 let, in se želite o tem pogovoriti, se, prosimo,
English: The MAH shall perform the required pharmacovigilance activities and interventions detailed in the agreed RMP presented in Module 1.8.2. of the Marketing Authorisation and any agreed subsequent updates of the RMP.
Slovenian: • Načrt za obvladovanje tveganja (RMP) Imetnik dovoljenja za promet z zdravilom bo izvedel zahtevane farmakovigilančne aktivnosti in ukrepe, podrobno opisane v sprejetem RMP, predloženem v modulu 1.8.2 dovoljenja za promet z zdravilom, in vseh nadaljnjih posodobitvah RMP.
English: To help you remember to take Cymbalta, you may find it easier to take it at the same times every day.
Slovenian: Morda se boste lažje spomnili vzeti zdravilo Cymbalta, če ga boste jemali vsak dan ob isti uri.
English: Your doctor may continue to give you Cymbalta when you are feeling better to prevent your depression or anxiety from returning
Slovenian: Vaš zdravnik vam bo morda še naprej predpisoval zdravilo Cymbalta, tudi ko se boste že bolje počutili, da bi preprečil ponoven pojav depresije ali anksioznosti.
English: Use in children and adolescents under 18 years of age Cymbalta should not be used in the treatment of children and adolescents under the age of 18 years.
Slovenian: Uporaba pri otrocih in mladostnikih, mlajših od 18 let Zdravila Cymbalta pri zdravljenju otrok in mladostnikov, mlajših od 18 let, ne smemo uporabljati.
English: What Cymbalta is and what it is used for What you need to know before you take Cymbalta How to take Cymbalta
Slovenian: Kaj je zdravilo Cymbalta in za kaj ga uporabljamo Kaj morate vedeti, preden boste vzeli zdravilo Cymbalta Kako jemati zdravilo Cymbalta
English: Do not stop taking Cymbalta, or change your dose, without talking to your doctor.
Slovenian: Ne prenehajte jemati zdravila Cymbalta in ne spreminjajte odmerka, ne da bi se posvetovali s svojim zdravnikom.
English: The main ingredient of Cymbalta, duloxetine, is used in other medicines for other conditions:
Slovenian: Poglavitno sestavino zdravila Cymbalta, duloksetin, uporabljamo tudi v drugih zdravilih za zdravljenje drugih bolezni:
English: Your doctor should decide whether you can take Cymbalta with other medicines.
Slovenian: Vaš zdravnik se mora odločiti, ali lahko jemljete zdravilo Cymbalta z drugimi zdravili.
English: • If you take Cymbalta near the end of your pregnancy there is an increased risk of excessive vaginal bleeding shortly after birth, especially if you have a history of bleeding disorders.
Slovenian: • Če zdravilo Cymbalta jemljete proti koncu nosečnosti, obstaja povečano tveganje za čezmerno krvavitev iz nožnice kmalu po porodu, sploh če ste v preteklosti že imeli motnje strjevanja krvi.
English: The European Medicines Agency has waived the obligation to submit the results of studies with Cymbalta in all subsets of the paediatric population in the treatment of major depressive disorder, diabetic neuropathic pain and generalised anxiety disorder.
Slovenian: Evropska agencija za zdravila je začasno odložila obvezo za predložitev rezultatov študij z zdravilom Cymbalta za vse skupine pediatrične populacije pri zdravljenju velike depresivne motnje, bolečine diabetične nevropatije in generalizirane anksiozne motnje.
English: You should inform your doctor if any of the symptoms listed above develop or worsen when patients under 18 are taking Cymbalta.
Slovenian: Svojega zdravnika obvestite, če se kateri od zgoraj naštetih simptomov pri bolniku, mlajšemu od 18 let, ki jemlje zdravilo Cymbalta, pojavi ali poslabša.
English: • If you take Cymbalta near the end of your pregnancy, your baby might have some symptoms when it is born.
Slovenian: • Če zdravilo Cymbalta jemljete proti koncu nosečnosti, se lahko po rojstvu pri vašem otroku pojavijo nekateri simptomi.
English: As the safety of duloxetine in infants is not known, the use of Cymbalta while breast-feeding is not recommended.
Slovenian: Ker varnost uporabe duloksetina pri dojenčkih ni znana, odsvetujemo uporabo zdravila Cymbalta med dojenjem.
English: What you need to know before you take Cymbalta DO NOT take Cymbalta if you:
Slovenian: Kaj morate vedeti, preden boste vzeli zdravilo Cymbalta NE jemljite zdravila Cymbalta, če:
English: Data on the use of Cymbalta 120 mg in elderly patients with major depressive disorder and generalised anxiety disorder are limited.
Slovenian: Podatkov o uporabi zdravila Cymbalta 120 mg pri starejših bolnikih z veliko depresivno motnjo in generalizirano anksiozno motnjo je malo.
English: Cymbalta may cause a sensation of restlessness or an inability to sit or stand still.
Slovenian: Zdravilo Cymbalta lahko povzroči občutek nemira ali nezmožnosti sedenja ali stanja pri miru.
English: If you take more Cymbalta than you should
Slovenian: Če ste vzeli večji odmerek zdravila Cymbalta, kot bi smeli
English: Cymbalta increases the levels of serotonin and noradrenaline in the nervous system.
Slovenian: Zdravilo Cymbalta zviša nivo serotonina in noradrenalina v živčnem sistemu.
English: Cymbalta showed comparable efficacy results to venlafaxine in terms of improvements on the HAM-A total score.
Slovenian: Cymbalta je pokazala primerljive rezultate učinkovitosti v primerjavi z venlafaksinom glede izboljšanja skupnega števila točk po HAM-A.
English: The initiation of treatment with Cymbalta is contraindicated in patients with uncontrolled hypertension that could expose patients to a potential risk of hypertensive crisis (see sections 4.4 and 4.8).
Slovenian: Uvedba zdravljenja z zdravilom Cymbalta je kontraindicirana pri bolnikih z nenadzorovano hipertenzijo, ki lahko izpostavi bolnike možnemu tveganju za hipertenzivno krizo (glejte poglavje 4.4 in 4.8).
English: The usual starting dose of Cymbalta is 30 mg once a day after which most patients will receive 60 mg once a day, but your doctor will prescribe the dose that is right for you.
Slovenian: Običajen začetni odmerek zdravila Cymbalta je 30 mg enkrat na dan, kasneje bo večina bolnikov prejela 60 mg enkrat na dan, vendar vam bo vaš zdravnik predpisal odmerek, ki je pravi za vas.
English: Other medicines and Cymbalta
Slovenian: Druga zdravila in zdravilo Cymbalta
English: Do not take more than the daily amount of Cymbalta that has been prescribed for you in one day.
Slovenian: Ne zaužijte več zdravila Cymbalta v enem dnevu, kot vam je bilo predpisano.
English: In both studies, Cymbalta 60 mg once daily and 60 mg twice daily significantly reduced pain compared with placebo.
Slovenian: V obeh študijah je Cymbalta 60 mg enkrat na dan in 60 mg dvakrat na dan značilno zmanjšal bolečino v primerjavi s placebom.
English: Major Depressive Disorder: Cymbalta was studied in a clinical programme involving 3,158 patients (1,285 patient-years of exposure) meeting DSM-IV criteria for major depression.
Slovenian: Klinična učinkovitost in varnost Velike depresivne motnje: zdravilo Cymbalta so preučevali v kliničnem programu, v katerem je sodelovalo 3.158 bolnikov (1.285 bolniških let izpostavljenosti), ki so izpolnjevali merila DSM-IV za veliko depresivno motnjo.
English: When stopping treatment with Cymbalta the dose should be gradually reduced over a period of at least one to two weeks in order to reduce the risk of withdrawal reactions (see sections 4.4 and 4.8).
Slovenian: Ob prenehanju zdravljenja z zdravilom Cymbalta je treba odmerek zdravila v obdobju najmanj enega do dveh tednov postopoma zmanjševati, da zmanjšamo tveganje za pojav odtegnitvenih reakcij (glejte poglavji 4.4 in 4.8).
English: • Cymbalta may cause effects that you may not be aware of, such as increases in liver enzymes or blood levels of potassium, creatine phosphokinase, sugar, or cholesterol
Slovenian: • zvečanje telesne mase • Cymbalta lahko povzroči tudi neželene učinke, ki se jih morda ne zavedate, kot povišanje jetrnih encimov ali krvnega nivoja kalija, kreatinske fosfokinaze, sladkorja ali holesterola.
English: • Make sure your midwife and/or doctor knows you are on Cymbalta.
Slovenian: • Svoji medicinski sestri, babici in/ali zdravniku povejte, da jemljete zdravilo Cymbalta.
English: Each capsule of Cymbalta contains pellets of duloxetine hydrochloride with a covering to protect them from stomach acid.
Slovenian: Vsaka kapsula zdravila Cymbalta vsebuje pelete duloksetinijevega klorida z oblogo za zaščito pred želodčno kislino.
English: Generalised Anxiety Disorder: Cymbalta demonstrated statistically significant superiority over placebo in five out of five studies including four randomised, double-blind, placebo-controlled acute studies and a relapse prevention study in adult patients with generalised anxiety disorder.
Slovenian: Generalizirana anksiozna motnja: Cymbalta se je izkazala za statistično značilno boljšo kot placebo v petih izmed petih študij, vključno s štirimi randomiziranimi, dvojno slepimi, s placebom kontroliranimi akutnimi študijami in študijo preprečevanja relapsa pri odraslih bolnikih z generalizirano anksiozno motnjo.
English: Cymbalta should normally not be used for children and adolescents under 18 years.
Slovenian: Zdravilo Cymbalta pri otrocih in mladostnikih, mlajših od 18 let, običajno ne uporabljamo.
English: Duloxetine did not show efficacy in reducing pain as measured by primary outcome measure of Brief Pain Inventory (BPI) average pain score endpoint: least squares (LS) mean change from baseline in BPI average pain score at 13 weeks was -0.97 in the placebo group, compared with -1.62 in the duloxetine 30/60 mg group (p = 0.052).
Slovenian: Duloksetin ni pokazal učinkovitosti pri zmanjševanju bolečine, izmerjene z merilom primarnega izida, tj. z opazovanim dogodkom povprečne ocene bolečine po vprašalniku BPI: povprečna sprememba po metodi najmanjših kvadratov (LS) od izhodišča povprečne ocene bolečine po vprašalniku BPI po 13 tednih je bila -0,97 v skupini, ki je prejemala placebo, in -1,62 v skupini, ki je prejemala duloksetin 30/60 mg (p = 0,052).
English: Cymbalta should be used with caution in patients with a history of mania or a diagnosis of bipolar disorder, and/or seizures.
Slovenian: Zdravilo Cymbalta je treba pri bolnikih z manijo v anamnezi ali z diagnozo bipolarne motnje in/ali epileptičnimi napadi uporabljati previdno.
English: The absolute oral bioavailability of duloxetine ranged from 32% to 80% (mean of 50%).
Slovenian: Absolutna peroralna biološka uporabnost duloksetina dosega vrednosti od 32 do 80 %
English: DO NOT stop taking your capsules without the advice of your doctor even if you feel better.
Slovenian: Če ste prenehali jemati zdravilo Cymbalta NE prenehajte jemati svojih kapsul, če vam ni tako svetoval vaš zdravnik, tudi če se bolje počutite.
English: Talk with your doctor about how long you should keep taking Cymbalta.
Slovenian: S svojim zdravnikom se pogovorite o tem, kako dolgo boste jemali zdravilo Cymbalta.
English: The most commonly reported adverse reactions in patients treated with Cymbalta were nausea, headache, dry mouth, somnolence, and dizziness.
Slovenian: Neželeni učinki, o katerih so pri bolnikih, zdravljenih z zdravilom Cymbalta, najpogosteje poročali, so bili slabost, glavobol suha usta, zaspanost in omotica.
English: Care should be taken if you drink alcohol while you are being treated with Cymbalta.
Slovenian: Bodite posebej previdni, če med zdravljenjem z zdravilom Cymbalta pijete alkohol.
English: Hyponatraemia may be due to a syndrome of inappropriate anti-diuretic hormone secretion (SIADH).
Slovenian: Hiponatriemija je lahko posledica sindroma neustreznega izločanja antidiuretičnega hormona (syndrome of inappropriate anti-diuretic hormone secretion,
English: • Tell your doctor if you become pregnant, or you are trying to become pregnant, while you are taking Cymbalta.
Slovenian: • Obvestite svojega zdravnika, če zanosite ali poskušate zanositi, medtem ko jemljete zdravilo
English: Diabetic Peripheral Neuropathic Pain: The efficacy of Cymbalta as a treatment for diabetic neuropathic pain was established in 2 randomised, 12-week, double-blind, placebo-controlled, fixed dose studies in adults (22 to 88 years) having diabetic neuropathic pain for at least 6 months.
Slovenian: Bolečina diabetične periferne nevropatije: učinkovitost zdravila Cymbalta kot zdravila za bolečino pri diabetični nevropatiji so ugotavljali v 2 randomiziranih 12-tedenskih dvojno slepih s placebom kontroliranih študijah z določenim odmerkom pri odraslih (starih od 22 do 88 let), ki so imeli bolečino diabetične nevropatije vsaj 6 mesecev.
English: Cymbalta should not be used in combination with fluvoxamine, ciprofloxacin or enoxacin (i.e. potent CYP1A2 inhibitors) since the combination results in elevated plasma concentrations of duloxetine (see section 4.5).
Slovenian: Zdravila Cymbalta ne smemo uporabljati v kombinaciji s fluvoksaminom, ciprofloksacinom ali enoksacinom (tj. močnimi zaviralci CYP1A2), saj kombinacija povzroči povišane plazemske koncentracije duloksetina (glejte poglavje 4.5).
English: Cymbalta is indicated in adults.
Slovenian: Zdravilo Cymbalta je indicirano za zdravljenje odraslih.
English: Tolerability of Cymbalta 60 mg once daily in elderly patients was comparable to that seen in the younger adults.
Slovenian: Prenašanje zdravila Cymbalta 60 mg enkrat na dan pri starejših bolnikih je bilo primerljivo s tistim, ki je bilo opaženo pri mlajših odraslih.
English: Cymbalta must not be used in patients with severe renal impairment (creatinine clearance <30 ml/min; see section 4.3).
Slovenian: Zdravila Cymbalta ne smemo uporabljati pri bolnikih s hudo okvarjenim delovanjem ledvic (očistek kreatinina < 30 ml/min; glejte poglavje 4.3).
English: Medicines like Cymbalta (so called SSRIs/SNRIs) may cause symptoms of sexual dysfunction (see section 4).
Slovenian: Zdravila, kot je zdravilo Cymbalta (t. i. SSRI/SNRI), lahko povzročijo simptome spolne disfunkcije
English: The antibiotic linezolid is a reversible non-selective MAOI and should not be given to patients treated with Cymbalta (see section 4.4).
Slovenian: Antibiotik linezolid je reverzibilen, neselektiven MAOI in ga bolniki, zdravljeni z zdravilom Cymbalta, ne smejo prejemati (glejte poglavje 4.4).
English: The incidence of relapse during the 6months double-blind follow-up period was 14% for Cymbalta and 42% for placebo.
Slovenian: Incidenca relapsa v 6-mesečnem obdobju dvojno slepega sledenja je bila 14 % pri prejemnikih zdravila Cymbalta oziroma 42 % pri prejemnikih placeba.
English: Hyponatraemia has been reported when administering Cymbalta, including cases with serum sodium lower than 110 mmol/l.
Slovenian: Ob dajanju zdravila Cymbalta so poročali o hiponatriemiji, vključno s primeri, ko je bila serumska koncentracija natrija pod 110 mmol/l.
English: The modelpredicted duloxetine steady state plasma concentrations in paediatric patients were mostly within the concentration range observed in adult patients.
Slovenian: Z modelom predvidene plazmske koncentracije duloksetina v stanju ravnotežja so bile večinoma znotraj obsega koncentracij,
English: Hypertension3,7 Orthostatic hypotension2
Slovenian: Hipertenzija3,7 ortostatska hipotenzija2 hladni periferni hipertenzivna kriza3,6
English: Cymbalta 60 mg is available in packs of 28, 56, 84 and 98 hard gastro-resistant capsules and in multipacks containing 100 (5 packs of 20) and 500 (25 packs of 20) hard gastro-resistant capsules.
Slovenian: Cymbalta 60 mg je na voljo v pakiranjih po 28, 56, 84 in 98 trdih gastrorezistentnih kapsul in v večjih pakiranjih, ki vsebujejo 100 (5 pakiranj po 20) oziroma 500 (25 pakiranj po 20) trdih gastrorezistentnih kapsul.
English: Cymbalta hard gastro-resistant capsules contain sucrose.
Slovenian: Cymbalta trde gastrorezistentne kapsule vsebujejo saharozo.
English: In clinical trials adverse events seen on abrupt treatment discontinuation occurred in approximately 45% of patients treated with Cymbalta and 23% of patients taking placebo.
Slovenian: V kliničnih preskušanjih so se neželeni učinki ob nenadni prekinitvi zdravljenja pojavili pri približno 45 % bolnikov, ki so jemali zdravilo Cymbalta in pri 23 % bolnikov, ki so dobivali placebo.
English: Cymbalta 60 mg once daily demonstrated a statistically significant superiority compared to placebo (p=0.004) on the primary outcome measure, the prevention of depressive relapse, as measured by time to relapse.
Slovenian: Cymbalta 60 mg enkrat na dan se je izkazalo za statistično značilno boljše v primerjavi s placebom (p = 0,004) pri merilu primarnega izida, preprečevanju relapsa depresije, kot so izmerili s časom do relapsa.
English: If you miss a dose, take it as soon as you remember.
Slovenian: Če ste pozabili vzeti zdravilo Cymbalta Če pozabite vzeti odmerek, ga zaužijte, kakor hitro se spomnite.
English: Consequently, caution is advised when Cymbalta is taken in combination with other centrally acting medicinal products or substances, including alcohol and sedative medicinal products (e.g. benzodiazepines, morphinomimetics, antipsychotics, phenobarbital, sedative antihistamines).
Slovenian: Cymbalta v kombinaciji z drugimi centralno delujočimi zdravili ali snovmi, ki vključujejo alkohol in pomirjevala (denimo benzodiazepini, morfinomimetiki, antipsihotiki, fenobarbital, sedirajoči antihistaminiki), potrebna previdnost.
English: Mydriasis has been reported in association with duloxetine, therefore, caution should be used when prescribing Cymbalta to patients with increased intraocular pressure, or those at risk of acute narrowangle glaucoma.
Slovenian: V povezavi z duloksetinom so poročali o midriazi, zato je pri predpisovanju zdravila Cymbalta bolnikom s povišanim intraokularnim tlakom ali s tveganjem za akutni glavkom z zaprtim zakotjem potrebna previdnost.
English: Cymbalta is used in adults to treat:
Slovenian: Cymbalta pri odraslih se uporablja za zdravljenje: • depresije
English: The usual dose of Cymbalta is 60 mg once a day, but your doctor will prescribe the dose that is right for you.
Slovenian: Običajen odmerek zdravila Cymbalta je 60 mg enkrat na dan, za vas ustrezen odmerek pa vam bo predpisal vaš zdravnik.
English: Excipient(s) with known effect Each capsule may contain up to 111 mg sucrose.
Slovenian: Ena kapsula lahko vsebuje do 111 mg saharoze.
English: Your doctor will tell you if you should be taking Cymbalta.
Slovenian: Vaš zdravnik vam bo povedal, če smete jemati zdravilo Cymbalta.
English: Cymbalta demonstrated statistical superiority over placebo as measured by improvement in the 17item Hamilton Depression Rating Scale (HAM-D) total score (including both the emotional and somatic symptoms of depression).
Slovenian: Cymbalta se je izkazala za statistično boljšo kot placebo, kar so izmerili z izboljšanjem skupnega števila točk po Hamiltonovi lestvici za ocenjevanje depresije s 17 postavkami (Hamilton Depression Rating Scale, HAM-D), ki vključuje čustvene in tudi somatske simptome depresije.
English: Therefore Cymbalta should not be administered in combination with potent inhibitors of CYP1A2 like fluvoxamine (see section 4.3).
Slovenian: Zato zdravila Cymbalta ne smemo dajati skupaj z močnimi zaviralci CYP1A2, denimo s fluvoksaminom (glejte poglavje 4.3).
English: The efficacy of Cymbalta 30-120 mg (flexible dosing) once a day in elderly patients (>65 years) with generalised anxiety disorder was evaluated in a study that demonstrated statistically significant improvement in the HAM-A total score for duloxetine treated patients compared to placebo treated patients.
Slovenian: Učinkovitost zdravila Cymbalta 30-120 mg (prilagodljivo odmerjanje) enkrat na dan pri starejših bolnikih (> 65 let) z generalizirano anksiozno motnjo je bila ocenjena v študiji, ki je pokazala statistično pomembno izboljšanje skupnega števila točk po lestvici HAM-A za bolnike, zdravljene z duloksetinom, v primerjavi z bolniki, ki so prejemali placebo.
English: In a relapse prevention study, patients responding to 6 months of acute treatment with open-label Cymbalta were randomised to either Cymbalta or placebo for a further 6-months.
Slovenian: V študiji preprečevanja relapsa so bolnike, ki so se odzvali na 6-tedensko akutno zdravljenje z znanim zdravilom Cymbalta, naključno razporedili v skupini, kjer so nadaljnjih 6 mesecev prejemali ali zdravilo Cymbalta ali placebo.
English: Patients should be instructed that if they experience sedation or dizziness they should avoid potentially hazardous tasks such as driving or operating machinery.
Slovenian: Zato je treba bolnikom naročiti, naj se izogibajo potencialno nevarnim nalogam,